A recent study shows that the plasminogen activator inhibitor-1 (PAI-1) contributes to impaired clot dissolution, a vital feature of the chronic nature of thromboembolism in CTEPH [20]. The gene discussed is SERPINE1; the disease is Thromboembolism.